Xamoterol

DB13781ApprovedSmall molecule

Xamoterol is a β1-adrenoceptor partial agonist that has shown to improve systolic and diastolic function in studies with heart failure patients. It modulates the sympathetic control of the heart but...

Mechanism: Pharmacologically active on Beta-1 adrenergic receptor
Curator reviewed
Formula / weight: C₁₆H₂₅N₃O₅ · 339.392 g/mol (avg)

Resolves to

Compound

UNII7HE0JQL703CAS81801-12-9ChEMBLCHEMBL75753ChEBI10055PubChem155774KEGGD06328

Clinical / RWD

RxNorm39801ATCC01CX07

Structure

InChIKeyDXPOSRCHIDYWHW-UHFFFAOYSA-NSMILESOC(CNCCNC(=O)N1CCOCC1)COC1=CC=C(O)C=C1

Targets

P08588ADRB1P13945ADRB3

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

672Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 17 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Xamoterol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account